Infectious diseases

Reven Publishes New COVID-19 Related Articles Outlining Clinical Impact Potential of Its RJX Platform

Health, Infectious diseases, Clinical trials, Research, Science, Pharmaceutical, Biotechnology, Medical specialties, Medicine, Health, Intensive care medicine, Respiratory diseases, Syndromes, Acute respiratory distress syndrome, Respiratory physiology, Respiratory distress syndrome, Infant respiratory distress syndrome, Clinical trial

Tuesday, July 7, 2020 - 1:09pm

Ph.D., and other members of the Reven team and their academic collaborators in the medical journal, Clinical Investigation (London).

Key Points:

Ph.D., and other members of the Reven team and their academic collaborators in the medical journal, Clinical Investigation (London).
The article also discusses the potential for the prevention of life-threatening complications from COVID-19 with RJX based on data obtained from clinical and non-clinical studies.
She provides the critical design elements for a two-cohort, two-part placebo-controlled, double-blind Phase 2 study of RJX in COVID-19 patients.
Clinical Impact Potential Of Rejuveinix (RJX) For Prevention Of Fatal Acute Respiratory Distress Syndrome (ARDS) And Multi-Organ Failure In Covid-19 Patients.

Bradley Corp. Shares Six Ways the Pandemic is Transforming Restroom Design

General Health, Restaurant, Bar, Infectious diseases, Health, Retail, Rooms, Toilets, Architecture, Visual arts, Construction, Sanitation, Furniture, Locker, Office equipment, Public toilet, Plumbing, Restroom

Tuesday, July 7, 2020 - 1:45pm

Companies, educational institutions and municipalities are all now evaluating new procedures and products for their restroom facilities.

Key Points:

Companies, educational institutions and municipalities are all now evaluating new procedures and products for their restroom facilities.
The goal is to create safe and healthy indoor environments that reduce the spread of airborne and surface contaminants.
Automatic door openers typically seen to support accessible design are now also being implemented in locations to prevent hand-surface contact.
is a leading manufacturer of commercial plumbing fixtures, washroom accessories, restroom partitions, emergency fixtures and solid plastic lockers.

Walter Isaacson Interviews MIT President Emerita Susan Hockfield on Overcoming the COVID-19 “Diagnostics Deficit” and How Convergence of Biology and Technology Will Drive 21st Century Innovation

Tuesday, July 7, 2020 - 1:00pm

Dr. Hockfield is author of the new book The Living Machine: How Biology will Build the Next Technology Revolution.

Key Points:

Dr. Hockfield is author of the new book The Living Machine: How Biology will Build the Next Technology Revolution.
From then on, I just discovered so many new technologies emerging from the convergence of biology with engineering and the hard sciences.
Its an exciting story and I think it is going to be the technology story of the 21st century.
The countries that have managed to control the coronavirus are countries that have been able to track and trace.

Cerus Corporation Reports Successful Inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma

Infectious diseases, Biotechnology, Health, Branches of biology, Transfusion medicine, Medical specialties, Blood products, Hematology, Blood, Platelet, Severe acute respiratory syndrome-related coronavirus, Severe acute respiratory syndrome

Tuesday, July 7, 2020 - 1:30pm

Cerus Corporation (Nasdaq:CERS) announced today study results demonstrating that the INTERCEPT Blood System inactivates SARS-CoV-2, the causative agent for COVID-19, in plasma components intended for transfusion.

Key Points:

Cerus Corporation (Nasdaq:CERS) announced today study results demonstrating that the INTERCEPT Blood System inactivates SARS-CoV-2, the causative agent for COVID-19, in plasma components intended for transfusion.
The investigators are currently conducting a subsequent study to assess the ability of the INTERCEPT Blood System to inactivate SARS-CoV-2 in platelet components.
Cerus Corporation is dedicated solely to safeguarding the worlds blood supply and aims to become the preeminent global blood products company.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

QLess Digital Line Management Promotes Social Distancing for Retailers

Software, Other Retail, Internet, Health, Infectious diseases, Technology, Mobile, Wireless, Retail, Merchandising, Consumer behaviour, Online shopping, Retail

Tuesday, July 7, 2020 - 4:00pm

QLess enables virtual check-ins through a dedicated online portal with real-time SMS updates about wait times and placements in line.

Key Points:

QLess enables virtual check-ins through a dedicated online portal with real-time SMS updates about wait times and placements in line.
Our system is used by hundreds of organizations in many industries, and is perfectly positioned to help solve the logistics of social distancing.
Retailers that use QLess have also seen up to a 75 percent reduction in walk-aways.
For more information about solutions by QLess for customer interaction management in the retail industry, please visit http://info.qless.com/blog/qless-coronavirus-solutions .

The Pershing Square Foundation Awards $3 Million to Innovative SARS-CoV-2 Research Projects

Tuesday, July 7, 2020 - 2:34pm

The Pershing Square Foundation (the Foundation) today announced that it has awarded $3 million to nineteen recipients at ten academic research institutions conducting research related to the SARS-CoV-2 virus.

Key Points:

The Pershing Square Foundation (the Foundation) today announced that it has awarded $3 million to nineteen recipients at ten academic research institutions conducting research related to the SARS-CoV-2 virus.
Since 2013, the Pershing Square Sohn Cancer Research Alliance has awarded over $22 million to 39 talented scientists.
The Pershing Square Sohn Cancer Research Alliance was formed in 2013 through a $25 million commitment by The Pershing Square Foundation, which partnered with The Sohn Conference Foundation.
Annually, the Alliance awards the Pershing Square Sohn Prize to young New York based scientists who are engaged in cutting-edge cancer research.

CytoAgents Receives Funding to Accelerate COVID-19 Clinical Trials for Cytokine Storm Treatment From Richard King Mellon Foundation

Biotechnology, Health, Other Health, Pharmaceutical, Other Philanthropy, Philanthropy, Other Science, Research, Infectious diseases, General Health, Hospitals, Foundation, Science, Clinical trials, Mellon family, Mellon

Tuesday, July 7, 2020 - 1:58pm

One of our goals is to seed quick solutions to the communitys most immediate healthcare needs, said Sam Reiman, Director of the Richard King Mellon Foundation.

Key Points:

One of our goals is to seed quick solutions to the communitys most immediate healthcare needs, said Sam Reiman, Director of the Richard King Mellon Foundation.
Its an honor to be selected for this funding from the Richard King Mellon Foundation, said Teresa Whalen, RPh , CEO, CytoAgents.
The $250,000 investment will accelerate the development of GP1681, which will be going into Phase 1 and Phase 2 human clinical trials in 2020.
Founded in 1947, the Richard King Mellon Foundation is the largest foundation in southwestern Pennsylvania.

Global Hospital Acquired Infection (HAI) Control Market 2020-2027 - Radiation Sterilization Equipment Corners a 19.8% Share in 2020 - ResearchAndMarkets.com

Infectious diseases, Hospitals, Health, Medical specialties, Medicine, Health, Healthcare quality, Hospital-acquired infection, Intensive care medicine, Infection

Tuesday, July 7, 2020 - 11:00am

The "Hospital Acquired Infection Control - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Hospital Acquired Infection Control - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
This segment currently accounts for a 25.9% share of the global Hospital Acquired Infection Control market.
The U. S. Accounts for Over 27% of Global Market Size in 2020, While China is Forecast to Grow at a 6% CAGR for the Period of 2020-2027
The Hospital Acquired Infection Control market in the U. S. is estimated at US$1.5 Billion in the year 2020.
In the global Radiation Sterilization Equipment segment, USA, Canada, Japan, China and Europe will drive the 2.5% CAGR estimated for this segment.

ChromaDex and the NIH-NIAID Rocky Mountain Laboratories Announce Study to Assess the Therapeutic Potential of Niagen® in COVID-19 Animal Models

Tuesday, July 7, 2020 - 11:34am

This study will assess if administration of Niagen (nicotinamide riboside, or NR) can reduce viral burden and inflammation in mouse and hamster models of COVID-19.

Key Points:

This study will assess if administration of Niagen (nicotinamide riboside, or NR) can reduce viral burden and inflammation in mouse and hamster models of COVID-19.
ChromaDexs patent-protected NR is a unique nutrient that supports cellular energy production and healthy mitochondrial function through efficient restoration of NAD+ levels.
The study is part of the ChromaDex External Research Program (CERP) in which ChromaDexs NR ingredient and placebos are provided to researchers at no cost.
The study will be conducted at the Rocky Mountain Labs (RML) of the NIH-NIAID.

New APM Study Reveals the Contribution of Projects and Project Management in the Health, Pharmaceutical and Life Sciences Sector

Health, Infectious diseases, Hospitals, Other Science, General Health, Science, Pharmaceutical, IEEE standards, Product development, APM, Project management, Business

Tuesday, July 7, 2020 - 9:00am

APM identified the healthcare sector (incorporating pharmaceutical and life sciences) as a key area of growth and professionalisation of project management.

Key Points:

APM identified the healthcare sector (incorporating pharmaceutical and life sciences) as a key area of growth and professionalisation of project management.
However, it is often the case that project teams are led by staff with no formal training in project management.
A lack of awareness of project management can increase the challenge of justifying investment in project management techniques.
Misconceptions of project management - The study highlights how there are common misperceptions of project management across the health sectors, often due to negative experiences of poor project implementation.